目次

Executive Summary
Market Overview

Market Landscape
Market ecosystem
Value chain analysis

Market Sizing
Market definition
Market segment analysis
Market size 2020
Market outlook: Forecast for 2020 - 2025

Five Forces Analysis
Bargaining power of buyers
Bargaining power of suppliers
Threat of new entrants
Threat of substitutes
Threat of rivalry
Market condition

Market Segmentation by End-user
Market segments
Comparison by End-user
Life science - Market size and forecast 2020-2025
Health centers - Market size and forecast 2020-2025
Others - Market size and forecast 2020-2025
Market opportunity by End-user

Customer landscape

Geographic Landscape
Geographic segmentation
Geographic comparison
North America - Market size and forecast 2020-2025
Europe - Market size and forecast 2020-2025
Asia - Market size and forecast 2020-2025
ROW - Market size and forecast 2020-2025
Key leading countries
Market opportunity By Geographical Landscape
Market drivers
Market challenges
Market trends

Vendor Landscape
Overview
Landscape disruption

Vendor Analysis
Vendors covered
Market positioning of vendors
Abbott Laboratories
Agilent Technologies Inc.
bioMerieux SA
F. Hoffmann-La Roche Ltd.
Illumina Inc.
Myriad Genetics Inc.
QIAGEN NV
Siemens Healthineers AG
Sysmex Corp.
Thermo Fisher Scientific Inc.

Appendix
Scope of the report
Currency conversion rates for US$
Research methodology
List of abbreviations

Exhibits
1: Key Finding 1
2: Key Finding 2
3: Key Finding 3
4: Key Finding 5
5: Key Finding 6
6: Key Finding 7
7: Key Finding 8
8: Parent market
9: Market characteristics
10: Offerings of vendors included in the market definition
11: Market segments
12: Global - Market size and forecast 2020 - 2025 ($ million)
13: Global market: Year-over-year growth 2020 - 2025 (%)
14: Five forces analysis 2020 & 2025
15: Bargaining power of buyers
16: Bargaining power of suppliers
17: Threat of new entrants
18: Threat of substitutes
19: Threat of rivalry
20: Market condition - Five forces 2020
21: End-user - Market share 2020-2025 (%)
22: Comparison by End-user
23: Life science - Market size and forecast 2020-2025 ($ million)
24: Life science - Year-over-year growth 2020-2025 (%)
25: Health centers - Market size and forecast 2020-2025 ($ million)
26: Health centers - Year-over-year growth 2020-2025 (%)
27: Others - Market size and forecast 2020-2025 ($ million)
28: Others - Year-over-year growth 2020-2025 (%)
29: Market opportunity by End-user
30: Customer landscape
31: Market share By Geographical Landscape 2020-2025 (%)
32: Geographic comparison
33: North America - Market size and forecast 2020-2025 ($ million)
34: North America - Year-over-year growth 2020-2025 (%)
35: Europe - Market size and forecast 2020-2025 ($ million)
36: Europe - Year-over-year growth 2020-2025 (%)
37: Asia - Market size and forecast 2020-2025 ($ million)
38: Asia - Year-over-year growth 2020-2025 (%)
39: ROW - Market size and forecast 2020-2025 ($ million)
40: ROW - Year-over-year growth 2020-2025 (%)
41: Key leading countries
42: Market opportunity By Geographical Landscape ($ million)
43: Impact of drivers and challenges
44: Vendor landscape
45: Landscape disruption
46: Industry risks
47: Vendors covered
48: Market positioning of vendors
49: Abbott Laboratories - Overview
50: Abbott Laboratories - Business segments
51: Abbott Laboratories - Key offerings
52: Abbott Laboratories - Key customers
53: Abbott Laboratories - Segment focus
54: Agilent Technologies Inc. - Overview
55: Agilent Technologies Inc. - Business segments
56: Agilent Technologies Inc. - Key offerings
57: Agilent Technologies Inc. - Key customers
58: Agilent Technologies Inc. - Segment focus
59: bioMerieux SA - Overview
60: bioMerieux SA - Business segments
61: bioMerieux SA - Key offerings
62: bioMerieux SA - Key customers
63: bioMerieux SA - Segment focus
64: F. Hoffmann-La Roche Ltd. - Overview
65: F. Hoffmann-La Roche Ltd. - Business segments
66: F. Hoffmann-La Roche Ltd. - Key offerings
67: F. Hoffmann-La Roche Ltd. - Key customers
68: F. Hoffmann-La Roche Ltd. - Segment focus
69: Illumina Inc. - Overview
70: Illumina Inc. - Product and service
71: Illumina Inc. - Key offerings
72: Illumina Inc. - Key customers
73: Illumina Inc. - Segment focus
74: Myriad Genetics Inc. - Overview
75: Myriad Genetics Inc. - Business segments
76: Myriad Genetics Inc. - Key offerings
77: Myriad Genetics Inc. - Key customers
78: Myriad Genetics Inc. - Segment focus
79: QIAGEN NV - Overview
80: QIAGEN NV - Business segments
81: QIAGEN NV - Key offerings
82: QIAGEN NV - Key customers
83: QIAGEN NV - Segment focus
84: Siemens Healthineers AG - Overview
85: Siemens Healthineers AG - Business segments
86: Siemens Healthineers AG - Key offerings
87: Siemens Healthineers AG - Key customers
88: Siemens Healthineers AG - Segment focus
89: Sysmex Corp. - Overview
90: Sysmex Corp. - Business segments
91: Sysmex Corp. - Key offerings
92: Sysmex Corp. - Key customers
93: Sysmex Corp. - Segment focus
94: Thermo Fisher Scientific Inc. - Overview
95: Thermo Fisher Scientific Inc. - Business segments
96: Thermo Fisher Scientific Inc. - Key offerings
97: Thermo Fisher Scientific Inc. - Key customers
98: Thermo Fisher Scientific Inc. - Segment focus
99: Currency conversion rates for US$
100: Research Methodology
101: Validation techniques employed for market sizing
102: Information sources
103: List of abbreviations